Interacciones medicamentosas potenciales en pacientes COVID 19 en tratamiento con lopinavir/ritonavir

OBJECTIVES: To determine the prevalence of potential interactions in COVID-19 patients receiving lopinavir/ritonavir (LPV/r). The secondary objective was to develop recommendations and identify the risk factors associated with presenting potential interactions with LPV/r. SUBJECTS AND METHODS: Cross...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandariz-Nuñez, David, Correas-Sanahuja, Marcelo, Guarc, Eva, Picón, Rafael, García, Bárbara, Gil, Rocío
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2020
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346810/
https://www.ncbi.nlm.nih.gov/pubmed/32718719
http://dx.doi.org/10.1016/j.medcli.2020.06.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346810/
https://www.ncbi.nlm.nih.gov/pubmed/32718719
http://dx.doi.org/10.1016/j.medcli.2020.06.026

Ejemplares similares